Faldaprevir, pegylated interferon, and ribavirin for treatment-naïve HCV genotype-1: pooled analysis of two phase 3 trials
Title:
Faldaprevir, pegylated interferon, and ribavirin for treatment-naïve HCV genotype-1: pooled analysis of two phase 3 trials
Author:
Jensen, Donald M. Asselah, Tarik Dieterich, Douglas Foster, Graham R. Sulkowski, Mark S. Zeuzem, Stefan Mantry, Parvez Yoshida, Eric M. Moreno, Christophe Ouzan, Denis Wright, Mark Morano, Luis E. Buynak, Robert Bourlière, Marc Hassanein, Tarek Nishiguchi, Shuhei Kao, Jia-Horng Omata, Masao Paik, Seung W. Wong, David K. Tam, Edward Kaita, Kelly Feinman, S. Victor Stern, Jerry O. Scherer, Joseph Quinson, Anne-Marie Voss, Florian Gallivan, John-Paul Böcher, Wulf O. Ferenci, Peter